Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 3, 2010, Pages 519-530

  Kalantar Zadeh, Kamyar ^a,b,c   Gutekunst, Lisa ^d   Mehrotra, Rajnish ^b   Kovesdy, Csaba P ^e,f   Bross, Rachelle ^a,b   Shinaberger, Christian S ^a,b,c   Noori, Nazanin ^a,b   Hirschberg, Raimund ^b   Benner, Debbie ^g   Nissenson, Allen R ^b,g   Kopple, Joel D ^a,b,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Cleve Hill Dialysis   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g DAVITA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOOD ADDITIVE; PHOSPHORUS; PHYTATE; PROTEIN;

BLOOD VESSEL CALCIFICATION; CHRONIC KIDNEY DISEASE; GASTROINTESTINAL ABSORPTION; HUMAN; HYPERPARATHYROIDISM; NUTRIENT; NUTRITION; NUTRITIONAL ASSESSMENT; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PALATABILITY; PLANT SEED; PRESCRIPTION; PROTEIN CONTENT; PROTEIN INTAKE; RENAL OSTEODYSTROPHY; RENAL REPLACEMENT THERAPY; REVIEW; VEGETABLE;

CHELATING AGENTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; COUNSELING; DIETARY PROTEINS; FOOD ADDITIVES; HUMANS; HYPERPHOSPHATEMIA; KIDNEY DISEASES; NUTRITIONAL STATUS; PHOSPHORUS, DIETARY; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 77749292030     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06080809     Document Type: Review

References (67)

1. Kovesdy CP, Trivedi BK, Anderson JE: Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: A historical prospective cohort study. Adv Chronic Kidney Dis 13: 183-188, 2006
2. Kovesdy CP, Kalantar-Zadeh K: Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol 40: 427-440, 2008
3. Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M: Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 19: 615-623, 2008
4. Isakova T, Gutierrez OM, Wolf M: A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease. Kidney Int 76: 705-716, 2009
5. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of timevarying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006
6. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
7. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS: Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167: 879-885, 2007
8. Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP: Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 1: 825-831, 2006
9. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633, 2005
10. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR: Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 20: 381-387, 2009
11. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA: Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20: 397-404, 2009
12. Hruska KA, Saab G, Mathew S, Lund R: Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial 20: 309-315, 2007
13. Krafft F: Phosphorus: From elemental light to chemical element. Angew Chem Int Ed Engl 8: 660-671, 1969
14. Sourkes TL: An element of thought: Phosphorus and mental philosophy in the nineteenth century. J Hist Neurosci 7: 108-124, 1998
15. Knochel JP: Phosphorus. In: Modern Nutrition in Health and Disease, 10th Ed., edited by Shils ME, Shike M, Ross AC, Caballero B, Baltimore, Lippincott Williams & Wilkins, 2006, pp 211-222
16. Okido M, Soloway RD, Crowther RS: Influence of phospholipid on bile salt binding to calcium hydroxyapatite and on the poisoning of nascent hydroxyapatite crystals. Liver 16: 321-325, 1996
17. Food and Nutrition Board: Phosphorus. In: Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride, edited by Institute of Medicine, Washington, DC, National Academy Press, 1997, pp 146-189
18. Ramirez JA, Emmett M, White MG, Fathi N, Santa Ana CA, Morawski SG, Fordtran JS: The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Int 30: 753-759, 1986
19. Savica V, Calo LA, Caldarera R, Cavaleri A, Granata A, Santoro D, Savica R, Muraca U, Mallamace A, Bellinghieri G: Phosphate salivary secretion in hemodialysis patients: Implications for the treatment of hyperphosphatemia. Nephron Physiol 105: 52-55, 2007
20. Kopple JD, Coburn JW: Metabolic studies of low protein diets in uremia: II. Calcium, phosphorus and magnesium. Medicine (Baltimore) 52: 597-607, 1973
21. Craver L, Marco MP, Martinez I, Rue M, Borras M, Martin ML, Sarro F, Valdivielso JM, Fernandez E: Mineral metabolism parameters throughout chronic kidney disease stages 1-5: Achievement of K/DOQI target ranges. Nephrol Dial Transplant 22: 1171-1176, 2007
22. Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C: Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: Evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract 110: c58-c65, 2008
23. Kalantar-Zadeh K, Kovesdy CP: Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol 4: 1529-1539, 2009
24. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K: Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73: 1296-1302, 2008
25. Grimm M, Muller A, Hein G, Funfstuck R, Jahreis G: High phosphorus intake only slightly affects serum minerals, urinary pyridinium crosslinks and renal function in young women. Eur J Clin Nutr 55: 153-161, 2001
26. Noori N, Kopple JD, Benner D, Kalantar-Zadeh K: High phosphorus intake is associated with poor survival in maintenance hemodialysis patients [Abstract]. J Am Soc Nephrol 20 [Suppl 1], 2009
27. Boaz M, Smetana S: Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake. J Am Diet Assoc 96: 1268-1270, 1996
28. Kayne LH, D'Argenio DZ, Meyer JH, Hu MS, Jamgotchian N, Lee DB: Analysis of segmental phosphate absorption in intact rats: A compartmental analysis approach. J Clin Invest 91: 915-922, 1993
29. Uribarri J: Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 20: 295-301, 2007
30. Colman S, Bross R, Benner D, Chow J, Braglia A, Arzaghi J, Dennis J, Martinez L, Baldo DB, Agarwal V, Trundnowski T, Zitterkoph J, Martinez B, Khawar OS, Kalantar-Zadeh K: The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: Overview of the NIED study and the role of dietitians. J Ren Nutr 15: 231-243, 2005
31. Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar-Zadeh K: Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 88: 1485-1494, 2008
32. Agarwal A, Agarwal R: More on predicting dietary phosphorus intake. J Am Diet Assoc 97: 583-584, 1997
33. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K: Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 88: 1511-1518, 2008
34. Bohn L, Meyer AS, Rasmussen SK: Phytate: Impact on environment and human nutrition-A challenge for molecular breeding. J Zhejiang Univ Sci B 9: 165-191, 2008
35. Sandberg AS, Andersson H, Kivisto B, Sandstrom B: Extrusion cooking of a high-fibre cereal product: 1. Effects on digestibility and absorption of protein, fat, starch, dietary fibre and phytate in the small intestine. Br J Nutr 55: 245-254, 1986
36. Lei XG, Porres JM: Phytase enzymology, applications, and biotechnology. Biotechnol Lett 25: 1787-1794, 2003
37. Sullivan C, Sayre SS, Leon JB, Machekano R, Love TE, Porter D, Marbury M, Sehgal AR: Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: A randomized controlled trial. JAMA 301: 629-635, 2009
38. Karp HJ, Vaihia KP, Karkkainen MU, Niemisto MJ, Lamberg-Allardt CJ: Acute effects of different phosphorus sources on calcium and bone metabolism in young women: A whole-foods approach. Calcif Tissue Int 80: 251-258, 2007
39. Sherman RA: Dietary phosphate restriction and protein intake in dialysis patients: A misdirected focus. Semin Dial 20: 16-18, 2007
40. Zhang H, Onning G, Oste R, Gramatkovski E, Hulthen L: Improved iron bioavailability in an oat-based beverage: The combined effect of citric acid addition, dephytinization and iron supplementation. Eur J Nutr 46: 95-102, 2007
41. Uribarri J, Calvo MS: Hidden sources of phosphorus in the typical American diet: Does it matter in nephrology? Semin Dial 16: 186-188, 2003
42. Kemi VE, Rita HJ, Karkkainen MU, Viljakainen HT, Laaksonen MM, Outila TA, Lamberg-Allardt CJ: Habitual high phosphorus intakes and foods with phosphate additives negatively affect serum parathyroid hormone concentration: A cross-sectional study on healthy premenopausal women. Public Health Nutr 12: 1885-1892, 2009
43. Sherman RA, Mehta O: Dietary phosphorus restriction in dialysis patients: Potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 54: 18-23, 2009
44. Sherman RA, Mehta O: Phosphorus and potassium content of enhanced meat and poultry products: Implications for patients who receive dialysis. Clin J Am Soc Nephrol 4: 1370-1373, 2009
45. Murphy-Gutekunst L: Hidden phosphorus: Where do we go from here? J Ren Nutr 17: e31-e36, 2007
46. Murphy-Gutekunst L: Hidden phosphorus in popular beverages. Nephrol Nurs J 32: 443-445, 2005
47. Karalis M, Murphy-Gutekunst L: Patient education: Enhanced foods-Hidden phosphorus and sodium in foods commonly eaten. J Ren Nutr 16: 79-81, 2006
48. Cupisti A, D'Alessandro C, Baldi R, Barsotti G: Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia. J Ren Nutr 14: 220-225, 2004
49. Murphy-Gutekunst L, Uribarri J: Hidden phosphorus-enhanced meats: Part 3. J Ren Nutr 15: E1-E4, 2005
50. Bell RR, Draper HH, Tzeng DY, Shin HK, Schmidt GR: Physiological responses of human adults to foods containing phosphate additives. J Nutr 107: 42-50, 1977
51. Sullivan CM, Leon JB, Sehgal AR: Phosphorus-containing food additives and the accuracy of nutrient databases: Implications for renal patients. J Ren Nutr 17: 350-354, 2007
52. Calvo MS: Dietary considerations to prevent loss of bone and renal function. Nutrition 16: 564-566, 2000
53. Calvo MS, Park YK: Changing phosphorus content of the U.S. diet: Potential for adverse effects on bone. J Nutr 126: 1168S-1180S, 1996
54. Uribarri J: Phosphorus additives in food and their effect in dialysis patients. Clin J Am Soc Nephrol 4: 1290-1292, 2009
55. Shafey TM, McDonald MW, Pym RA: Effects of dietary calcium, available phosphorus and vitamin D on growth rate, food utilisation, plasma and bone constituents and calcium and phosphorus retention of commercial broiler strains. Br Poult Sci 31: 587-602, 1990
56. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]: S1-S201, 2003
57. Shinaberger CS, Kilpatrick RD, Regidor DL, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K: Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis 48: 37-49, 2006
58. Oenning LL, Vogel J, Calvo MS: Accuracy of methods estimating calcium and phosphorus intake in daily diets. J Am Diet Assoc 88: 1076-1080, 1988
59. Kovesdy CP, Mehrotra R, Kalantar-Zadeh K: Battleground: Chronic kidney disorders mineral and bone disease: Calcium obsession, vitamin D, and binder confusion. Clin J Am Soc Nephrol 3: 168-173, 2008
60. Shantouf R, Budoff MJ, Ahmadi N, Tiano J, Flores F, Kalantar-Zadeh K: Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients. Am J Nephrol 28: 275-279, 2007
61. Cozzolino M, Brancaccio D: Hyperphosphatemia in dialysis patients: The therapeutic role of lanthanum carbonate. Int J Artif Organs 30: 293-300, 2007
62. Qunibi WY, Nolan CR: Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: Results of the CARE study. Kidney Int Suppl S33-S38, 2004
63. Kuhlmann MK, Hoechst S, Landthaler I: Patient empowerment in the management of hyperphosphatemia. Int J Artif Organs 30: 1008-1013, 2007
64. USDA Nutrient Database for Standard Reference, Release 21, Washington, DC, USDA
65. The Loma Linda University Diet Manual: A Handbook Supporting Vegetarian Nutrition, Loma Linda, CA, Loma Linda University, 2003
66. Nepro package insert, Cleveland, Abbott Nutrition, November 2009
67. Novasource Renal package insert, Highland Park, MI, Nestle Nutrition, November 2009